{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:10:34Z","timestamp":1793729434609,"version":"4.6.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013798","name":"Bladder Cancer Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013798","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020895","name":"University of Toronto Temerty Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.eururo.2025.09.4145","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T22:13:11Z","timestamp":1759875191000},"page":"404-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Development and International Evaluation of an Artificial Intelligence\u2013based Model (PROGRxN-BCa) Using the World Health Organization 2004\/2022 Grading System to Predict Progression Risk and Improve Substratification for Non\u2013muscle-invasive Bladder Cancer"],"prefix":"10.1016","volume":"89","author":[{"given":"Jethro C.C.","family":"Kwong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizo","family":"Al-Daqqaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashan","family":"Chelliahpillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soomin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellie","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximiliano","family":"Ringa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Feifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Lajkosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian S.","family":"Wettstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeweon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myky","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim","family":"Kassouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney H.","family":"Breau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Lodde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Fairey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Lattouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Jeldres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Rendon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimira","family":"Alimohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil E.","family":"Fleshner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Diamand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gontero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Sylvester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas W.G.","family":"van Rhijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish M.","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair E.W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre R.","family":"Zlotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6929-6124","authenticated-orcid":false,"given":"Girish S.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2025.09.4145_b0005","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.09.4145_b0010","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.09.4145_b0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/JU.0000000000004305","article-title":"Long-term recurrence risk, metastatic potential, and length of cystoscopic surveillance of low-grade non-muscle-invasive bladder cancer","volume":"213","author":"Villegas","year":"2025","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.09.4145_b0020","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of Urology (EAU) prognostic factor risk groups for non\u2013muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC Guidelines Panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.09.4145_b0025","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.eururo.2024.07.027","article-title":"European Association of Urology guidelines on non\u2013muscle-invasive bladder cancer (TaT1 and carcinoma in situ)\u2014a summary of the 2024 guidelines update","volume":"86","author":"Gontero","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.09.4145_b0030","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.euo.2021.11.006","article-title":"Updated European Association of Urology (EAU) prognostic factor risk groups overestimate the risk of progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Gu\u00e9rin","volume":"5","author":"Lobo","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2025.09.4145_b0035","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1016\/S2589-7500(23)00067-5","volume":"5","author":"Kwong","year":"2023","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.eururo.2025.09.4145_b0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.35377","article-title":"APPRAISE-AI tool for quantitative evaluation of AI studies for clinical decision support","volume":"6","author":"Kwong","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eururo.2025.09.4145_b0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41746-024-01088-7","article-title":"Predicting non-muscle invasive bladder cancer outcomes using artificial intelligence: a systematic review using APPRAISE-AI","volume":"7","author":"Kwong","year":"2024","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.eururo.2025.09.4145_b0050","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.euo.2022.05.005","article-title":"Intermediate-risk non-muscle-invasive bladder cancer: updated consensus definition and management recommendations from the International Bladder Cancer Group","volume":"5","author":"Tan","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2025.09.4145_b0055","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/sim.7992","article-title":"Minimum sample size for developing a multivariable prediction model: part II\u2014binary and time-to-event outcomes","volume":"38","author":"Riley","year":"2019","journal-title":"Stat Med"},{"key":"10.1016\/j.eururo.2025.09.4145_b0060","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.euf.2021.07.004","article-title":"Standardized reporting of machine learning applications in urology: the STREAM-URO framework","volume":"7","author":"Kwong","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2025.09.4145_b0065","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2025.09.4145_b0070","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","volume":"400","author":"Comp\u00e9rat","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2025.09.4145_b0075","series-title":"Proceedings of the 39th International Conference on Machine Learning","first-page":"9916","article-title":"HyperImpute: generalized iterative imputation with automatic model selection","author":"Jarrett","year":"2022"},{"key":"10.1016\/j.eururo.2025.09.4145_b0080","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"10.1016\/j.eururo.2025.09.4145_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/bimj.202200302","article-title":"Stability of clinical prediction models developed using statistical or machine learning methods","volume":"65","author":"Riley","year":"2023","journal-title":"Biom J"},{"key":"10.1016\/j.eururo.2025.09.4145_b0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.euo.2021.05.006","article-title":"Deep learning-based recalibration of the CUETO and EORTC prediction tools for recurrence and progression of non-muscle-invasive bladder cancer","volume":"5","author":"Jobczyk","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2025.09.4145_b0095","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1016\/S2589-7500(22)00003-6","article-title":"The medical algorithmic audit","volume":"4","author":"Liu","year":"2022","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.eururo.2025.09.4145_b0100","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.euo.2024.06.004","article-title":"Clinical validation of the intermediate-risk non-muscle-invasive bladder cancer scoring system and substratification model proposed by the International Bladder Cancer Group: a multicenter Young Academic Urologists Urothelial Working Group collaboration","volume":"7","author":"Soria","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2025.09.4145_b0105","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/his.12214","article-title":"An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps","volume":"63","author":"Comp\u00e9rat","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.eururo.2025.09.4145_b0110","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.eururo.2017.04.015","volume":"72","author":"Soukup","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.09.4145_b0115","first-page":"192","article-title":"Predicting response to intravesical bacillus Calmette-Gu\u00e9rin in high-risk nonmuscle-invasive bladder cancer using an artificial intelligence-powered pathology assay: development and validation in an international 12-center cohort","volume":"213","author":"Lotan","year":"2025","journal-title":"J Urol"},{"issue":"16_suppl","key":"10.1016\/j.eururo.2025.09.4145_b0120","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1200\/JCO.2023.41.16_suppl.4510","article-title":"Tumour factors and the variation in non-muscle invasive bladder cancer recurrence after transurethral resection surgery between sites: results from the RESECT study","volume":"41","author":"Gaba","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2025.09.4145_b0125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1056\/NEJMc2104626","article-title":"The clinician and dataset shift in artificial intelligence","volume":"385","author":"Finlayson","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2025.09.4145_b0130","doi-asserted-by":"crossref","first-page":"E307","DOI":"10.5489\/cuaj.7810","article-title":"Building the Canadian Bladder Cancer Research Network (CBCRN): progress during a pandemic","volume":"16","author":"Black","year":"2022","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.eururo.2025.09.4145_b0135","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.euo.2020.12.002","article-title":"Prognostic value of the WHO1973 and WHO2004\/2016 classification systems for grade in primary Ta\/T1 non-muscle-invasive bladder cancer: a multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel study","volume":"4","author":"van Rhijn","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2025.09.4145_b0140","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.eururo.2011.10.026","article-title":"A new and highly prognostic system to discern T1 bladder cancer substage","volume":"61","author":"van Rhijn","year":"2012","journal-title":"Eur Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283825046883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283825046883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T20:11:25Z","timestamp":1778962285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283825046883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0302283825046883"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2025.09.4145","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and International Evaluation of an Artificial Intelligence\u2013based Model (PROGRxN-BCa) Using the World Health Organization 2004\/2022 Grading System to Predict Progression Risk and Improve Substratification for Non\u2013muscle-invasive Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2025.09.4145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}